Osteoarthritis Trial, Recruiting NCT05487274 Sponsor: Ottawa Hospital Research Institute Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT05487274
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with idiopathic shoulder osteoarthritis (wear-and-tear of the shoulder joint with no known cause)
  • People whose shoulder osteoarthritis has not improved after at least 6 months of non-surgical treatment, including pain medications, anti-inflammatory drugs, physiotherapy, and changes to daily activities
  • People whose imaging and surgical findings show advanced loss of cartilage in the shoulder joint
  • People who have a specific type of shoulder socket problem where the socket is angled backwards between 15.1 and 26 degrees
  • People aged 65 years or older

Who may not be able to join:

  • People with an active infection in the joint or elsewhere in the body
  • People whose shoulder condition involves damage to the rotator cuff tendons (rotator cuff arthropathy)
  • People with significant muscle weakness or paralysis in the shoulder
  • People with Charcot's arthropathy, a condition involving nerve-related joint damage (confirm with trial site)
  • People with serious medical conditions where life expectancy is less than one year, or where surgery would carry an unacceptably high risk
  • People who are unable to understand or complete the consent process
  • People who are pregnant
  • People with a psychiatric illness that prevents them from giving informed consent
  • People who are unwilling to attend follow-up appointments for the full duration of the study
  • People whose shoulder socket angle cannot be surgically corrected to within 10 degrees of a neutral position
  • People who have previously had surgery on the affected shoulder
  • People who have rheumatoid arthritis in the affected shoulder

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Peter Lapner, MD FRCSC, The Ottawa Hospital

Phone: 613-737-8899

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ottawa Hospital Research Institute
Registry
ClinicalTrials.gov
Start date
9 August 2022
Est. completion
31 March 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Western Ontario Osteoarthritis of the Shoulder Index (WOOS); Western Ontario Osteoarthritis of the Shoulder Index (WOOS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov